C4 Therapeutics Announces FDA Orphan Drug Designation for CFT745

Long

C4 Therapeutics, Inc. (NASDAQ:CCCC)

NASDAQ:CCCC C4 Therapeutics, Inc.

beyondta

CCCC: C4 Therapeutics, Inc.
2021-08-11 16:01:00
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.